Menstruation and Menstrual Health

Table of Contents

Menstrual health sits in a strange cultural blind spot. It affects roughly half the population for a significant portion of their lives, and yet it's routinely minimized, both by the people experiencing it and by the healthcare systems meant to support them. Three separate bodies of research make this blind spot hard to ignore once you've actually seen the numbers: how common and disruptive menstrual pain genuinely is, how long it can take for a serious underlying condition to be diagnosed, and how many people simply cannot reliably afford the products needed to manage a period at all.

The Menstrual Cycle as a Vital Sign

Major medical organizations have moved decisively away from treating menstruation as a peripheral topic. The American College of Obstetricians and Gynecologists has explicitly recommended that clinicians treat the menstrual cycle as an additional vital sign in adolescent patients, comparable in principle to blood pressure or pulse, precisely because patterns of menstrual bleeding can reveal underlying health issues, including hormonal disorders, nutritional problems, or reproductive conditions, well before they show up anywhere else. This framing matters because it directly challenges a common instinct, in both patients and clinicians, to treat menstrual irregularity or pain as simply something to tolerate rather than something worth formally evaluating.

Menstrual Pain Is Extremely Common, and Extremely Under-Addressed

Painful periods, medically termed dysmenorrhea, are not a minor or rare complaint. A widely cited critical review found that in adolescents specifically, reported prevalence ranges from 16% to 93% depending on the study population and definition used, with severe pain reported by 2% to 29% of the girls studied (Iacovides, Avidon, & Baker, 2015). A cross-sectional study of university students in Ethiopia found a según prevalence of 80% among the sample studied, with more than half reporting moderate to severe pain (dysmenorrhea prevalence study, Hawassa University, 2021). A separate multicenter study of medical students similarly found dysmenorrhea prevalence at 78.4%, with most students reporting feeling more agitated, more tired, and having noticeably less energy for daily activities during their periods (dysmenorrhea impact study, medical students, 2022).

What's especially striking is how normalized this pain has become despite its measurable impact. A study of high school students in Jakarta found that 93% of female students perceived dysmenorrhea as simply normal, even though the same pain was shown to significantly and measurably affect exam performance, concentration, and school participation (dysmenorrhea impact study, Jakarta, Indonesia). Notably, this study found actual absenteeism was low, present in only about 13% of cases, suggesting that most students affected by significant menstrual pain still show up and push through it rather than staying home, a pattern researchers call presenteeism. A separate large study of working women in Egypt quantified this same phenomenon precisely, finding a presenteeism rate of 96.1% among women with dysmenorrhea, alongside a 94.2% rate of impaired daily activity, even though outright absenteeism from work was considerably lower (dysmenorrhea and work productivity study, Egypt).

Population studied Reported dysmenorrhea prevalence
Adolescents (global range across studies) 16% to 93%
University students, Ethiopia 80%
Medical students (multicenter study) 78.4%
Working women, Egypt 66.1%
Presenteeism, Not Just Absenteeism Most research on menstrual pain's real-world cost focuses on how often people miss school or work entirely. The more consistent and arguably more important finding across multiple studies is presenteeism: showing up while significantly impaired, which shows up repeatedly across the research even when outright absence stays relatively low.

When Pain Signals Something More: The Endometriosis Diagnostic Delay

For a meaningful share of people with severe menstrual pain, the underlying cause is a specific medical condition called endometriosis, in which tissue similar to the uterine lining grows outside the uterus, causing chronic pain and, in many cases, infertility. Multiple large-scale studies converge on one deeply concerning pattern: it takes an extraordinarily long time, on average, for this condition to be formally diagnosed. A 2024 scoping review synthesizing 23 studies from multiple countries found an average diagnostic delay of 6.8 years, with individual country averages ranging from 1.5 to 11.4 years (understanding diagnostic delay for endometriosis, scoping review, 2024). A large French e-cohort study following nearly 7,000 participants found an even longer average delay of 10 years for endometriosis and 11 years for the related condition adenomyosis (ComPaRe-Endometriosis cohort study, 2026).

Qualitative research examining why these delays happen paints a troubling picture. A UK study interviewing women about their diagnostic journeys found that 46% had experienced symptoms for more than 10 years before receiving a diagnosis, and identified delays occurring at both the individual patient level and within the medical system itself (Ballard et al., 2006). More recent qualitative research examining healthcare professionals' own perspectives found something particularly worth naming directly: professionals described how endometriosis symptoms are often dismissed or rendered invisible, and specifically noted that the presence of another person, most often a male partner, in a consultation could influence how seriously a patient's pain was taken and whether a referral was made (exploring delay to diagnosis of endometriosis, healthcare professional perspective study). Contributing factors identified across this research consistently include normalization of severe pain by patients, families, and clinicians alike, limited clinical awareness of the condition, and the continued absence of a simple, non-invasive diagnostic test (diagnostic delay in endometriosis review, 2025).

A decade is a strange amount of time to wait for confirmation that pain someone has been managing alone was real all along.

A line worth sitting with before dismissing anyone's reported pain, including your own

Period Poverty: A Barrier That's Larger Than Assumed

A third body of research addresses a more basic barrier: simply being able to afford menstrual products at all. In 2021, researcher Lauren Cardoso and colleagues surveyed a nationally drawn sample of 471 college-attending women in the United States and found that 14.2% had experienced period poverty, meaning an inability to afford needed menstrual products, at least once in the past year, with an additional 10% experiencing it every single month (Cardoso, Scolese, Hamidaddin, & Gupta, 2021). The same study found period poverty was significantly associated with elevated depression symptoms, even after adjusting for other demographic factors (Cardoso et al., 2021). Subsequent national research tracking trends over time found that period product insecurity in the United States actually increased between 2018 and 2021, rather than improving (period product insecurity trends study, Journal of Women's Health).

Common Misunderstandings, Cleared Up

"Isn't menstrual pain just something everyone deals with, not really a medical issue?"

Widespread does not mean medically insignificant. Research shows dysmenorrhea measurably affects concentration, academic performance, and productivity, and severe or worsening pain can be an early sign of an underlying condition like endometriosis, which on average takes years to diagnose (Iacovides et al., 2015; endometriosis diagnostic delay scoping review, 2024).

"Is period poverty mainly a problem in low-income countries?"

No. Research specifically conducted among U.S. college students found meaningful rates of period poverty, and found the problem trending in the wrong direction over time, worsening between 2018 and 2021 (Cardoso et al., 2021; period product insecurity trends study).

"If a doctor doesn't seem concerned about menstrual pain, does that mean it's probably nothing serious?"

Not necessarily. Research on diagnostic delay specifically identifies normalization of pain by clinicians themselves, alongside patients, as a major contributing factor to years-long delays in diagnosing real underlying conditions (diagnostic delay in endometriosis review, 2025). Persistent, worsening, or activity-limiting pain is worth continued advocacy, including a second opinion if needed.

Applying This Practically

  1. Track cycle length, pain severity, and impact on daily function over several months, treating the pattern itself as clinically meaningful information, in line with how major medical bodies now frame the menstrual cycle.
  2. Recognize the difference between typical mild discomfort and pain that measurably limits concentration, attendance, or daily activity, since the latter is exactly the pattern linked to years-long diagnostic delays when dismissed as ordinary.
  3. If pain is consistently severe or worsening, seek a second medical opinion rather than accepting normalization as a final answer, given how long diagnostic delays for conditions like endometriosis have been shown to run.
  4. Be aware that period poverty is a documented issue even in wealthy countries and among college populations, not a distant problem; consider what access to menstrual products looks like in your own school, workplace, or community.

References

Ballard, K., Lowton, K., & Wright, J. (2006). What's the delay? A qualitative study of women's experiences of reaching a diagnosis of endometriosis. Fertility and Sterility, 86(5), 1296–1301.

Cardoso, L. F., Scolese, A. M., Hamidaddin, A., & Gupta, J. (2021). Period poverty and mental health implications among college-aged women in the United States. BMC Women's Health, 21, Article 14. https://doi.org/10.1186/s12905-020-01149-5

Diagnostic delay in endometriosis: Is there any progress? (2025). [Journal article]. ScienceDirect.

Endometriosis diagnostic delay and its correlates: Results from the ComPaRe-Endometriosis cohort. (2026). Journal of Women's Health. Advance online publication.

Exploring delay to diagnosis of endometriosis, a healthcare professional perspective. (2025). [Journal article, qualitative study].

Iacovides, S., Avidon, I., & Baker, F. C. (2015). What we know about primary dysmenorrhea today: A critical review. Human Reproduction Update, 21(6), 762–778. https://doi.org/10.1093/humupd/dmv039

Understanding diagnostic delay for endometriosis: A scoping review using the social-ecological framework. (2024). Health Care for Women International. Advance online publication. https://doi.org/10.1080/07399332.2024.2413056

Post a Comment

Your questions, insights, and feedback inspire us and help make this space vibrant and engaging. Every comment shows us that our content is reaching you, motivating us to keep writing and sharing more.

Here’s how you can contribute:

Ask Freely: If you’re curious about something, don’t hesitate to ask!
Help Others: Know the answer to someone’s question? Share your knowledge and insights.
Be Respectful: Share your views in a kind and constructive way.
Stay Relevant: Keep the discussion focused and helpful for everyone.

Let’s make this a space where everyone feels welcome to share their thoughts. Thank you for being part of our community!